| HGNC Family | Secretoglobins (SCGB) |
| Name | secretoglobin, family 2A, member 2 |
| Description | Predicted to be involved in androgen receptor signaling pathway. Predicted to be located in extracellular region. Predicted to be active in extracellular space. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSCGB2A2, also known as mammaglobin‐A, is a secretoglobin family protein that is predominantly expressed in normal mammary epithelium and markedly overexpressed in breast carcinoma. Its high specificity for mammary tissue underlies its extensive study as a diagnostic biomarker. Numerous investigations have demonstrated that sensitive methods—including RT‐PCR and immunohistochemistry—can detect SCGB2A2 transcripts or protein in primary breast tumors as well as in circulating tumor cells, sentinel lymph nodes, and peripheral blood, thereby facilitating early diagnosis and detection of micrometastases. These studies highlight significant correlations between SCGB2A2 expression and breast cancer presence in both localized and advanced disease settings."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "7"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its utility in primary tumor detection, SCGB2A2 plays a critical role in the differential diagnosis of metastatic lesions. Its expression distinguishes metastatic breast carcinomas from malignancies of other origins—including salivary gland neoplasms, lung carcinomas, and central nervous system tumors—by serving as an immunohistochemical signature of breast origin. In addition, investigations in various body fluids such as pleural effusions have demonstrated that SCGB2A2 detection can enhance the sensitivity of conventional cytologic analyses, while its expression is often associated with hormone receptor–positive disease and lower histologic grade. Together, these findings support its clinical application not only in confirming breast origin but also in assisting prognosis through correlation with nodal status and other predictive parameters."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "8", "end_ref": "20"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its well‐established diagnostic and prognostic applications, emerging evidence suggests that SCGB2A2 may influence breast cancer biology. Functional studies indicate that altered SCGB2A2 expression can modulate cell proliferation, migration, invasion, and epithelial–mesenchymal transition through pathways including MAPK and NF‐κB. Moreover, its immunogenic properties have been explored for the development of breast cancer vaccines, and SCGB2A2‐derived epitopes have been shown to elicit CD8⁺ cytotoxic T cell responses. These findings not only reinforce the importance of SCGB2A2 as a biomarker for detecting disseminated disease but also open avenues for its use as a target in immune intervention strategies."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "21", "end_ref": "33"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Michail Ignatiadis, Galatea Kallergi, Maria Ntoulia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-07-4758"}], "href": "https://doi.org/10.1158/1078-0432.CCR-07-4758"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18451221"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18451221"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Eiichi Sasaki, Nobuyuki Tsunoda, Yutaka Hatanaka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Breast-specific expression of MGB1/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mod Pathol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/modpathol.3800731"}], "href": "https://doi.org/10.1038/modpathol.3800731"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17192791"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17192791"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Maria Ntoulia, Aliki Stathopoulou, Michail Ignatiadis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Biochem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.clinbiochem.2006.06.009"}], "href": "https://doi.org/10.1016/j.clinbiochem.2006.06.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16925986"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16925986"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Rodney J Ouellette, Dominique Richard, Emmanuel Maïcas "}, {"type": "b", "children": [{"type": "t", "text": "RT-PCR for mammaglobin genes, MGB1 and MGB2, identifies breast cancer micrometastases in sentinel lymph nodes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Clin Pathol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1309/MMAC-TXT5-5L8Q-TKC1"}], "href": "https://doi.org/10.1309/MMAC-TXT5-5L8Q-TKC1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15151203"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15151203"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "S Roncella, P Ferro, B Bacigalupo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Clin Cancer Res (2005)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16110760"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16110760"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Nuno Cerveira, Lurdes Torres, Patrícia Rocha, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Highly sensitive detection of the MGB1 transcript (mammaglobin) in the peripheral blood of breast cancer patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.11609"}], "href": "https://doi.org/10.1002/ijc.11609"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14696125"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14696125"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Neil A O'Brien, Norma O'Donovan, Bríd Ryan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mammaglobin a in breast cancer: existence of multiple molecular forms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.20780"}], "href": "https://doi.org/10.1002/ijc.20780"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15609337"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15609337"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Justin A Bishop, Raluca Yonescu, Denise Batista, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Pathol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.humpath.2013.03.017"}], "href": "https://doi.org/10.1016/j.humpath.2013.03.017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23773480"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23773480"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Gloria H Lewis, Andrea Proctor Subhawong, Hind Nassar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Relationship between molecular subtype of invasive breast carcinoma and expression of gross cystic disease fluid protein 15 and mammaglobin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Clin Pathol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1309/AJCPMFR6OA8ICHNH"}], "href": "https://doi.org/10.1309/AJCPMFR6OA8ICHNH"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21411781"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21411781"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Yuji Takeda, Koji Tsuta, Yasuo Shibuki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Pathol Lab Med (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.5858/2008-132-239-AOEPOB"}], "href": "https://doi.org/10.5858/2008-132-239-AOEPOB"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18251583"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18251583"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Yun-Bi Ni, Julia Y S Tsang, Mu-Min Shao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GATA-3 is superior to GCDFP-15 and mammaglobin to identify primary and metastatic breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Breast Cancer Res Treat (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10549-017-4645-2"}], "href": "https://doi.org/10.1007/s10549-017-4645-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29340880"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29340880"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Lei Huo, Jinxia Zhang, Michael Z Gilcrease, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Histopathology (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1365-2559.2012.04344.x"}], "href": "https://doi.org/10.1111/j.1365-2559.2012.04344.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22963676"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22963676"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Yan Chen, Tian Ning Zou, Zhi Ping Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Detection of cytokeratin 19, human mammaglobin, and carcinoembryonic antigen-positive circulating tumor cells by three-marker reverse transcription-PCR assay and its relation to clinical outcome in early breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biol Markers (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/172460081002500201"}], "href": "https://doi.org/10.1177/172460081002500201"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20586026"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20586026"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Z Yan, J Gidley, D Horton, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Diagnostic utility of mammaglobin and GCDFP-15 in the identification of metastatic breast carcinoma in fluid specimens."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diagn Cytopathol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/dc.21039"}], "href": "https://doi.org/10.1002/dc.21039"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19217055"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19217055"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Yuqiong Yang, Shanming Lu, Wenqin Zeng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GATA3 expression in clinically useful groups of breast carcinoma: a comparison with GCDFP15 and mammaglobin for identifying paired primary and metastatic tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Diagn Pathol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.anndiagpath.2016.09.011"}], "href": "https://doi.org/10.1016/j.anndiagpath.2016.09.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28038704"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28038704"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "G Gargano, V Agnese, V Calò, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Oncol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/annonc/mdl948"}], "href": "https://doi.org/10.1093/annonc/mdl948"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16760290"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16760290"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "P Gimbergues, M M Dauplat, A Cayre, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Surg Oncol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ejso.2006.09.013"}], "href": "https://doi.org/10.1016/j.ejso.2006.09.013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17071045"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17071045"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "M Raica, Anca Maria Cîmpean, Adriana Meche, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Analysis of the immunohistochemical expression of mammaglobin A in primary breast carcinoma and lymph node metastasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Rom J Morphol Embryol (2009)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19690758"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19690758"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "GuangLiang Li, Jing Zhang, KeTao Jin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human mammaglobin: a superior marker for reverse-transcriptase PCR in detecting circulating tumor cells in breast cancer patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomark Med (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2217/bmm.11.20"}], "href": "https://doi.org/10.2217/bmm.11.20"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21473729"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21473729"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Supinda Chusakul, Chuntima Phannaso, Siraprapa Tongkobpetch, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of mammaglobins A and B in nasal polyps is similar in patients with and without allergic rhinitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Rhinol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2500/ajr.2008.22.3138"}], "href": "https://doi.org/10.2500/ajr.2008.22.3138"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18416968"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18416968"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Monica M Reinholz, Kathleen A Kitzmann, Kathleen Tenner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group trials, N0234/336/436/437."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-11-0981"}], "href": "https://doi.org/10.1158/1078-0432.CCR-11-0981"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21976532"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21976532"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Ankur R Sangoi, Bijayee Shrestha, George Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Novel Marker GATA3 is Significantly More Sensitive Than Traditional Markers Mammaglobin and GCDFP15 for Identifying Breast Cancer in Surgical and Cytology Specimens of Metastatic and Matched Primary Tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Appl Immunohistochem Mol Morphol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/PAI.0000000000000186"}], "href": "https://doi.org/10.1097/PAI.0000000000000186"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25906123"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25906123"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Kaidi Mikhitarian, Renee Hebert Martin, Megan Baker Ruppel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Detection of mammaglobin mRNA in peripheral blood is associated with high grade breast cancer: interim results of a prospective cohort study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2407-8-55"}], "href": "https://doi.org/10.1186/1471-2407-8-55"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18289390"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18289390"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "S Roncella, P Ferro, B Bacigalupo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Relationship between human mammaglobin mRNA expression in breast cancer tissue and clinico-pathologic features of the tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Clin Cancer Res (2006)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16761620"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16761620"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Pier Francesco Ferrucci, Cristina Rabascio, Chiara Mazzetta, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mammaglobin expression in leukapheresis products is a predictive marker of poor prognosis in women with high-risk breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-03-0453"}], "href": "https://doi.org/10.1158/1078-0432.CCR-03-0453"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15447988"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15447988"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Iman Mamdouh Talaat, Mahmood Yaseen Hachim, Ibrahim Yaseen Hachim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Bone marrow mammaglobin-1 (SCGB2A2) immunohistochemistry expression as a breast cancer specific marker for early detection of bone marrow micrometastases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-020-70012-2"}], "href": "https://doi.org/10.1038/s41598-020-70012-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32747636"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32747636"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Carsten T Viehl, Daniel M Frey, Chanpheng Phommaly, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Generation of mammaglobin-A-specific CD4 T cells and identification of candidate CD4 epitopes for breast cancer vaccine strategies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Breast Cancer Res Treat (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10549-007-9657-x"}], "href": "https://doi.org/10.1007/s10549-007-9657-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17653857"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17653857"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Anna Sjödin, Ingrid Ljuslinder, Roger Henriksson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mammaglobin and lipophilin B expression in breast tumors and their lack of effect on breast cancer cell proliferation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Anticancer Res (2008)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18630503"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18630503"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "G-W Lee, J-Y Kim, E-H Koh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Plasma human mammaglobin mRNA associated with poor outcome in patients with breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genet Mol Res (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4238/2012.November.28.2"}], "href": "https://doi.org/10.4238/2012.November.28.2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23212340"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23212340"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Venkataswarup Tiriveedhi, Nayan J Sarma, Vijay Subramanian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of HLA-A24-restricted CD8(+) cytotoxic T-cell epitopes derived from mammaglobin-A, a human breast cancer-associated antigen."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Immunol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.humimm.2011.10.017"}], "href": "https://doi.org/10.1016/j.humimm.2011.10.017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22074997"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22074997"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Nadia Picot, Roxann Guerrette, Annie-Pier Beauregard, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mammaglobin 1 promotes breast cancer malignancy and confers sensitivity to anticancer drugs."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Carcinog (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mc.22358"}], "href": "https://doi.org/10.1002/mc.22358"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26207726"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26207726"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "V K Bozhenko, N V Kharchenko, E F Vaskevich, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[Mammaglobin in peripheral blood and tumor in breast cancer patients]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Khim (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18097/PBMC20166204453"}], "href": "https://doi.org/10.18097/PBMC20166204453"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27563000"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27563000"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Kjersti Tjensvoll, Satu Oltedal, Ragne K Farmen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Breast Cancer (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3816/CBC.2010.n.050"}], "href": "https://doi.org/10.3816/CBC.2010.n.050"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20920982"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20920982"}]}]}]}
|
| Synonyms | MGB1, UGB2 |
| Proteins | SG2A2_HUMAN |
| NCBI Gene ID | 4250 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
SCGB2A2 has 8,466 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 86 datasets.
Click the + buttons to view associations for SCGB2A2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SCGB2A2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SCGB2A2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of SCGB2A2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SCGB2A2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of SCGB2A2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SCGB2A2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of SCGB2A2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of SCGB2A2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of SCGB2A2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with SCGB2A2 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SCGB2A2 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of SCGB2A2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of SCGB2A2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of SCGB2A2 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SCGB2A2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with SCGB2A2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with SCGB2A2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of SCGB2A2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with SCGB2A2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with SCGB2A2 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with SCGB2A2 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with SCGB2A2 gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by SCGB2A2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with SCGB2A2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with SCGB2A2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with SCGB2A2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with SCGB2A2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SCGB2A2 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SCGB2A2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of SCGB2A2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GAD Gene-Disease Associations | diseases associated with SCGB2A2 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with SCGB2A2 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of SCGB2A2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with SCGB2A2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing SCGB2A2 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of SCGB2A2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SCGB2A2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of SCGB2A2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SCGB2A2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of SCGB2A2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of SCGB2A2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GlyGen Glycosylated Proteins | ligands (chemical) binding SCGB2A2 protein from the GlyGen Glycosylated Proteins dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving SCGB2A2 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving SCGB2A2 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving SCGB2A2 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing SCGB2A2 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by SCGB2A2 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of SCGB2A2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of SCGB2A2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SCGB2A2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with SCGB2A2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with SCGB2A2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with SCGB2A2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of SCGB2A2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of SCGB2A2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of SCGB2A2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for SCGB2A2 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of SCGB2A2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of SCGB2A2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of SCGB2A2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of SCGB2A2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of SCGB2A2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of SCGB2A2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SCGB2A2 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain SCGB2A2 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting SCGB2A2 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of SCGB2A2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of SCGB2A2 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of SCGB2A2 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for SCGB2A2 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SCGB2A2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving SCGB2A2 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving SCGB2A2 protein from the Wikipathways PFOCR 2024 dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SCGB2A2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of SCGB2A2 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of SCGB2A2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of SCGB2A2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of SCGB2A2 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of SCGB2A2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of SCGB2A2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of SCGB2A2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SCGB2A2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of SCGB2A2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SCGB2A2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with SCGB2A2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with SCGB2A2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |